Pharmacists on the Multidisciplinary Team: Implementing Best Practices in Chemo-Induced Nausea and Vomiting (CINV) Management
This Continuing Education activity is supported by educational grants from Eisai Inc., Merck Sharp & Dohme Corp., and Tesaro, Inc.
This activity is supported by educational grants from Eisai Inc., Merck Sharp & Dohme Corp., and Tesaro, Inc.
Sally Yowell Barbour, PharmD, BCOP, CPP
Director of Oncology Pharmacy Programs
Duke University Hospital
Durham, North Carolina
Jeannette Y. Wick, RPh, MBA, FASCP
Freelance Medical Writer
University of Connecticut School of Pharmacy
After completing this continuing education program, the participant will be able to:
- Identify guideline-consistent care that recommends antiemetic regimens for chemo-induced nausea and vomiting (CINV)
- Explain safety and efficacy profiles for established regimens and new antiemetic strategies for CINV
- Illustrate strategies for managing challenging situations such as breakthrough symptoms, delayed CINV, managing nausea, and providing antiemetic regimens for multiday chemotherapy
- Examine a multidisciplinary approach to patient education, communication, and ongoing assessment that is most likely to improve outcomes in CINV
Target audience: Pharmacists, health system pharmacists, specialty pharmacists
Type of activity: Application
Release date: September 8, 2016
Expiration date: September 8, 2017
Estimated time to complete activity: 2.0 hours
Pharmacy Times Continuing Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 2.0 contact hours (0.20 CEUs) under the ACPE universal activity number 0290-0000-16-120-H01-P. The activity is available for CE credit through September 8, 2017.